BlackRock Fund Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-13,252
Closed -$316K 3838
2014
Q3
$316K Sell
13,252
-946
-7% -$21.8K ﹤0.01% 3311
2014
Q2
$328K Sell
14,198
-518
-4% -$11.4K ﹤0.01% 3311
2014
Q1
$336K Buy
14,716
+1,256
+9% +$26.8K ﹤0.01% 3324
2013
Q4
$249K Hold
13,460
﹤0.01% 3377
2013
Q3
$228K Sell
13,460
-5,060
-27% -$85.1K ﹤0.01% 3347
2013
Q2
$287K Buy
+18,520
New +$308K ﹤0.01% 3226

Other funds holding NVO

BlackRock Fund Advisors's NVO Position: Q4 2014 in Review

BlackRock Fund Advisors sold out of Novo Nordisk (NVO) in Q4 2014, closing a stake of 13,252 shares — an estimated $316K sold.

BlackRock Fund Advisors first reported a position in NVO in Q2 2013 and held it in 6 quarters. The position peaked at $336K in Q1 2014. 500 funds tracked by Wall St. Rank hold NVO as of Q4 2014.

  • BlackRock Fund Advisors reported no remaining Novo Nordisk position as of Q4 2014 after selling out during the quarter.
  • BlackRock Fund Advisors sold 13,252 Novo Nordisk shares in Q4 2014, an estimated $316K.
  • BlackRock Fund Advisors first reported a position in Novo Nordisk in Q2 2013 and held it in 6 quarters.
  • BlackRock Fund Advisors's Novo Nordisk position peaked at $336K in Q1 2014.
  • 500 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2014.

Based on BlackRock Fund Advisors's 13F filing for Q4 2014, filed 9 Feb 2015.